Untimely results from Moderna coronavirus vaccine assessment show participants succeeded antibodies against the virus
*Volunteers who received Moderna’s Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.*
If future findings end up well, the company’s vaccine could be in the doorstep of the public as early as January, Dr. Tal Zaks, Moderna’s chief medical officer, told CNN.
“This is absolutely good news and news that we think many have been waiting for for quite some time,” Zaks said.
These untimely data come from the Phase 1 clinical test, which typically studies a small number of people and focuses on whether a vaccine is reliable and elicits an immune response or not.
The results of the study, which was led by the National Institutes of Health, have not been peer write up or published in a medical journal yet.